Board Member

Transforming Challenges into Opportunities

Partnering to Enhance Life Sciences Value

As a board member of a life sciences company, you bring invaluable experience and strategic insight to guide the organization forward. At SSI Strategy, we appreciate the crucial role you play and the decisions you face in driving the company's growth and long-term value creation. 

Increasing Value

Our proven approaches increase enterprise value and support teams in any growth format. Whether overseeing a single company or a portfolio, partnering with SSI Strategy, you can be confident that the organizations under your guidance are well-positioned to achieve critical milestones and inflection points more efficiently, ultimately driving up book value and maximizing returns. We understand the importance of immediate progress, regardless of the team's current skill gaps or the complexity of the programs.

We can support and improve any form of governance or execution to assist with churn, turnover, or missing skills, ensuring that progress is maintained, and the company stays on track to achieve its goals. 

Reducing Risk

By supplementing drug developer expertise, we help de-risk programs. Our approach provides stability and reduces the likelihood of setbacks, giving you peace of mind that your investments are in good hands. We'll work collaboratively with the company's team to identify and bridge any clinical or regulatory gaps that may be hindering progress. Time is of the essence in the life sciences industry, and we focus on finding viable paths forward for companies or teams responding to regulatory or clinical challenges.

Our team helps executive teams manage the early build with record speed and functional depth, ensuring that the organization can move quickly and efficiently towards its objectives. 

Improving Momentum

Maintaining strong market momentum is essential for investor confidence and fundraising. By enabling executive teams to manage the early build phase more effectively, we help companies maintain and improve their market momentum, positioning them for success. If the organization is facing difficulties or needs to change course, SSI Strategy is here to help.

We assist executives in hitting clinical and regulatory milestones, focusing on progress rather than politics. Our turnaround support can be the difference between failure and success. 

Let's Explore Collaboration

If the company you oversee is facing challenges or you're looking for a thought partner for the journey ahead, we're here to support you. Let's open a dialogue to learn more about the organization's unique story and explore how we can collaborate to write the next chapter of success.

Together, we can drive meaningful advancements in the life sciences industry. 

LEADERSHIP

Doug Locke

CEO

Kim Kushner

CBO

Adam Schwartz

President

LET’S TALK

You don't have to go it alone!

Our experienced team has been there before, and we're ready to guide you through the unknown. Share your challenges with us, and together, we'll create a plan to efficiently reach your milestones and turn your vision into reality.

Building Better Biotechs

This field is for validation purposes and should be left unchanged.